Bell, J. Simon
La Caze, Adam
Steeper, Michelle
Haines, Terry P.
Hilmer, Sarah N.
Troeung, Lakkhina
Quirke, Lyntara
Wesson, Jacqueline
Pond, Constance Dimity
Buys, Laurie
Ghahreman-Falconer, Nazanin
Lawless, Michael T.
Shrestha, Shakti
Martini, Angelita
Ochieng, Nancy
Glamorgan, Francesca
Lagasca, Carmela
Walton, Rebecca
Cenin, Dayna
Kitson, Alison
Jung, Monica
Bennett, Alexandra
Cross, Amanda J. https://orcid.org/0000-0001-6001-9211
Funding for this research was provided by:
Australian Government Medical Research Future Fund (GA187306)
National Health and Medical Research Council (Emerging Leadership 1 grant (APP2009633))
Article History
Received: 29 December 2023
Accepted: 13 February 2024
First Online: 4 March 2024
Declarations
:
: The trial has received Monash University Human Research Ethics Committee approval (ID 35525). The research will be conducted in accordance with the World Medical Association Declaration of Helsinki. The trial evaluates RACF-level interventions, and individual residents will not be recruited to participate. The aged care provider organisations were partners in the application for grant funding. RACF-level consent to participate was obtained from an authorised representative of the aged care provider organisation or RACF manager. If an aged care provider organisation or RACF manager decides to withdraw throughout the trial, data that have been collected prior to withdrawal will be included in the data analysis if permitted. No new data will be collected after the aged care provider organisation or RACF has withdrawn from the trial. Any planned changes in the protocol will be approved by the ethics committee, communicated to relevant stakeholders, and updated in the ANZCTR.
: Not applicable.
: J. S. B. has received grant funding or consulting funds from the National Health and Medical Research Council, Medical Research Future Fund, Victorian Government Department of Health and Human Services, Dementia Australia Research Foundation, Yulgilbar Foundation, Aged Care Quality and Safety Commission, Dementia Centre for Research Collaboration, Pharmaceutical Society of Australia, Society of Hospital Pharmacists of Australia, GlaxoSmithKline Supported Studies Programme, Amgen, and several aged care provider organisations unrelated to this work. All grants and consulting funds were paid to the employing institution. J. W. was previously employed at Montefiore Homes and continues to have a professional links with them, including paid mentoring roles. A. J. C. has received grant funding or consulting funds from the Medical Research Future Fund and Pharmaceutical Society of Australia. All grants and consulting funds were paid to the employing institution. The other authors declare that they have no competing interests.